Four days after hearing oral arguments in a challenge to the constitutionality of a task force within the Department of ...

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

Summer is creeping closer, and for Gilead Sciences that only means one thing: the much-anticipated launch of long-acting HIV ...

The Trump Administration has gutted many areas of healthcare funding and research, especially in infectious diseases. One ...

Data from the last five years show that many people who contracted HIV had seen a provider in the year before.

The Supreme Court will hear oral arguments on Monday in yet another dispute over the separation of powers. The case is a ...

The Supreme Court will hear oral arguments Monday in a case that could upend cost-free coverage of preventive healthcare ...

SPRINGFIELD The Illinois Department of Public Health (IDPH) has issued a standing order that will allow Illinoisans to obtain ...

Despite steep budget and staffing cuts at the FDA in recent weeks and other headwinds, Gilead CEO Daniel O’Day assured investors that the pharma’s plans and preparations for lenacapavir’s launch ...

By Sunita Sohrabji The Supreme Court heard oral arguments April 21 in a case that could upend free preventive screenings and services for people insured via the Affordable Care ...

But on Monday, the US Supreme Court heard oral arguments in a case that could gut the part of the Affordable Care Act that ...